Triazolyl aminopyrimidine compounds

Details for Australian Patent Application No. 2008254319 (hide)

Owner Eli Lilly and Company

Inventors Henry, James Robert; Li, Hong-Yu; Sawyer, Jason Scott; Slater, Melissa Kate; Jiang, Delu; McMillen, William Thomas; Hu, Hong; Brooks, Harold Burns; Wang, Yan; Crich, Joyce Z.

Agent Spruson & Ferguson

Pub. Number AU-B-2008254319

PCT Pub. Number WO2008/144223

Priority 60/938,347 16.05.07 US

Filing date 7 May 2008

Wipo publication date 27 November 2008

Acceptance publication date 19 April 2012

International Classifications

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/144223 Priority application(s): WO2008/144223

19 April 2012 Application Accepted

  Published as AU-B-2008254319

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008254328-A treatment simulator for brain diseases and method of use thereof

2008254318-Triazolyl aminopyrimidine compounds